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Abstract
The conjugation of ubiquitin to substrates requires a series of enzymatic reactions consisting of an
activating enzyme (E1), conjugating enzymes (E2) and ligases (E3). Tagging the appropriate
substrate with ubiquitin is achieved by specific E2-E3 and E3-substrate interactions. E6AP, a member
of the HECT family of E3s, has been previously shown to bind and function with the E2s UbcH7
and UbcH8. To decipher the sequence determinants of this specificity we have developed a
quantitative E2-E3 binding assay based on fluorescence polarization and used this assay to measure
the affinity of wild type and mutant E2–E6AP interactions. Alanine scanning of the E6AP–UbcH7
binding interface identified 4 side chains on UbcH7 and 6 side chains on E6AP that contribute more
than 1 kcal /mol to the binding free energy. Two of the hot spot residues from UbcH7 (K96 and
K100) are conserved in UbcH8 but vary across other E2s. To determine if these are key specificity
determining residues, we attempted to induce a tighter association between the E2 UbcH5b and E6AP
by mutating the corresponding positions in UbcH5b to lysines. Surprisingly, the mutations had little
effect, but rather a mutation at UbcH7 position 4, which is not at a hot spot on the UbcH7–E6AP
interface, significantly strengthened UbcH5bs affinity for E6AP. This result indicates that E2-E3
binding specificities are a function of both favorable interactions that promote binding, and
unfavorable interactions that prevent binding with unwanted partners.
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Introduction
Protein ubiquitination is an essential eukaryotic pathway that influences nearly all cellular
processes1. The conjugation of ubiquitin to a protein substrate requires a cascade of enzymatic
reactions beginning with the ubiquitin activating enzyme (E1). The E1 uses ATP to form a
thioester bond between the carboxyl-terminus of ubiquitin and the E1 active site cysteine. The
E1 then binds a ubiquitin conjugating enzyme (E2) and transfers ubiquitin to the E2 active site
cysteine. The next step in the pathway requires a ubiquitin ligase (E3) which utilizes distinct
domains to bind both E2 and substrate. The two major classes of E3s bind E2s using either a
RING (really interesting gene) domain or a HECT (homology to E6AP carboxy terminus)
domain. E3s containing a HECT domain form a third thioester intermediate with ubiquitin
prior to transfer to substrate2. E3s that contain a RING domain do not form a covalent
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intermediate with ubiquitin, but rather bring the substrate in proximity of the E2 whereby
transfer of ubiquitin proceeds directly from E2 to substrate.
The importance of specific E3-substrate interactions is apparent as aberrations can lead to
improper substrate regulation and severe physiological consequences3; 4. Often overlooked is
the specificity of E2-E3 interactions as similar outcomes could potentially arise. The
hierarchical nature of the ubiquitin pathway presents a formidable task in dissecting all E2-E3
and E3-substrate interactions. For example in humans there is a single E1, ∼30 E2s and
hundreds of potential E3s. In general, a given E2 will interact with multiple E3s while E3s only
function with a limited subset of E2s4. Additionally, a given E3 may have more than one
substrate and some substrates can be recognized by multiple E3s4. One possible method to
dissect the network of interactions is to design altered specificity E2-E3 pairs that will function
together but not with their wild type partners. Such an approach has been taken by Marc
Timmers and colleagues who used a charge swap interaction across the UbcH5b–cNOT4
interface to create an altered specificity E2-RING pair5. The Timmers study, as well as others,
have helped map the determinants of E2-RING specificity5; 6; 7; 8; 9. Here, we examine the
sequence determinants of E2-HECT specificity. In particular, we focus on the HECT domain
protein, E6AP.
E6AP is the founding member of the HECT domain class of E3s. It was first identified as a
protein that cooperates with the E6 protein from oncogenic forms of the human papillomavirus
to down regulate the p53 tumor suppressor10. The conserved ∼350 amino acid HECT domain
adopts a bilobal structure and is always found at the C-terminus of E3s. A three residue hinge
connects the N-terminal, E2 binding lobe with the catalytic C-terminal lobe and the interface
created by the two lobes forms a highly conserved cleft containing the catalytic cysteine11
(Figure 1(a)). Three crystal structures of HECT domains have revealed significantly different
orientations of the two lobes implying conformational changes are necessary for catalysis11;
12; 13. Hinge mutations to proline that restrict the conformational flexibility of the HECT
domain result in impaired E3 activity12. Also, some patients with Angelman syndrome (AS),
a severe neurological disorder linked to E6AP, have acquired mutations within the conserved
cleft which have been shown to reduce E6AP ligase activity14; 15. Despite the significant
progress on AS associated E6AP mutations, none of the identified E6AP substrates have been
directly linked to the disorder16. A better understanding of HECT domains as well as their E2s
and substrates may help combat such E3 associated diseases.
All E2 enzymes possess a conserved catalytic core domain of approximately 150 amino acids
though some E2s also contain N- and C-terminal extensions which serve diverse
functions16. The E2 core domain contains the residues responsible for catalysis as well as
binding E1 and E3s. Crystal structures of the E2 UbcH7 bound to a HECT E3, E6AP11, and
a RING E3, c-Cbl17, revealed that E2s utilize similar residues to bind both classes of E3s. The
majority of E3 binding residues are contained within the N-terminal helix (helix 1) as well as
loops 4 and 7 11; 17 (Figure 1(b)). In both E2-E3 structures, the primary contact at the interface
arises from F63 on loop 4 of UbcH7 which is buried in a hydrophobic groove created by the
E311; 17. This phenylalanine is present in all E2s that have been shown to function with HECT
E3s11; 18. The sequences of helix 1 and loop 7 of HECT binding E2s are more varied, and it
has been proposed that these regions of the interface determine which HECT domains an E2
will bind11. HECT E3s have been shown to form selective interactions with at least 3 distinct
E2 subfamilies19; 20; 21; 22. To decipher the sequence determinants of E2-E6AP specificity,
we have performed a variety of mutagenesis experiments to map out which E2 and E6AP
residues are important for E2-E6AP affinity, and have used this information along with multiple
sequence alignments to rationally perturb E2-E6AP binding preferences.
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Results
E6AP selectivity for UbcH7 and UbcH8
Previous two-hybrid studies and activity assays indicate that E6AP binds and functions with
the E2s UbcH7 and UbcH8, and to a lesser extent UbcH5a19; 20. To more precisely quantitate
these preferences and test a larger set of E2s, we measured the binding affinity of E6AP for 9
E2s using a fluorescence polarization (FP) assay that we previously used to measure UbcH7-
E6AP binding23. E2s were selectively labeled at cysteine side-chains using a thiol-reactive
bodipy dye, and fluorescence polarization of the modified E2 was monitored as a function of
E3 concentration. To ensure that the bodipy labeling of the E2s was not influencing binding,
we measured the binding affinity of unmodified UbcH7 for E6AP using isothermal titration
calorimetry (ITC) (Supplementary Figure 1). The two experiments yielded similar measures
of the UbcH7-E6AP dissociation constant (KD of 5.0 M from FP and 2.2 M from ITC). Of the
E2s tested only UbcH8 contained a cysteine near the HECT-binding interface and for this
reason we used a C97S UbcH8 mutant in our FP assays.
Four of the E2s (Ubc9, UbcH10, Rad6b, and Ubc12) lack a phenylalanine at position 63 (F63)
and were not expected to bind E6AP (Figure 2(a)). The E2s with a F63 represent three distinct
E2 subfamilies according to a recent phylogenetic analysis of E2 enzymes24. Representatives
of the UBC4/5 subfamily include yeast UBC4 and its human homolog UbcH5b (UbcH5a
paralog). The human UbcH2 protein belongs to the UBC8 subfamily while human UbcH7 and
UbcH8 represent the UbcH7/8 subfamily. The binding assays show that only UbcH7 and
UbcH8(C97S) bind to E6AP with low micromolar affinity (Figure 2(b)). The other E2s with
a phenylalanine at position 63 (UBC4, UbcH5b, and UbcH2) bind E6AP with affinities less
than 200 M. Of the E2s lacking F63, UbcH10, Rad6b, and Ubc12 did not bind E6AP. Ubc9,
the SUMO-conjugating enzyme, was able to weakly interact with E6AP. These results are
consistent with previous findings that show HECT E3s preferentially interact with E2s
containing a phenylalanine at position 6311; 18.
Identifying hot spot residues at the UbcH7–E6AP interface
Having confirmed the importance of F63 to binding E6AP, we next set out to identify secondary
determinants that provide E6AP selectivity for the UbcH7/8 subfamily. We used alanine
scanning of the E6AP-UbcH7 interface followed by binding measurements to determine which
side chains contribute most to binding. 36 residues at the interface were mutated to either
alanine or glycine. The mutants were expressed in E. coli. and binding affinities were measured
with the FP binding assay.
The free energy of binding for the wild type UbcH7–E6AP interaction was measured at 7.2
kcal/mol (KD = 5.0 M). As expected, the mutation resulting in the largest loss of binding energy
was F63A (ΔΔG°bind = 3.0 kcal/mol). None of the other mutants tested lost more than 2 kcal/
mol, but 9 mutants lost greater than 1 kcal/mol. Together with F63 these residues will be
referred to as hot spots (Table 1). Of these 9 mutants, 4 are hydrophobic E6AP residues (L635A,
L639A, L642A, and F690A) that form van der Waals contacts with F63 (Figure 3). An
unexpected finding was that two UbcH7 loop 7 lysine residues, K96 and K100, were binding
hot spots. In the crystal structure, K96 forms a salt bridge with D641 of E6AP while the K100
hydrogen bonds with the D652 backbone carbonyl of E6AP. Hot spots were also observed at
a completely conserved proline preceding F63 as well as M653 and Y645 of E6AP. The latter
two residues form van der Waals contacts with P97 and A98 of UbcH7 loop 7. Of the remaining
mutants we found 16 to be moderately destabilizing (ΔΔG°bind of 0.25 to 1.0 kcal/mol). These
residues are a mixture of polar, charged, and hydrophobic amino acids. Interestingly these
residues form a shell around the hydrophobic hot spot residues of UbcH7 and E6AP (Figure
3). Like the reciprocating hydrophobic hot spots, moderately destabilizing residues of UbcH7
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interact with moderately destabilizing residues of E6AP. The final 10 mutants exhibited either
neutral (ΔΔG°bind of −0.25 to 0.25 kcal/mol) or stabilizing (ΔΔG°bind < −0.25 kcal/mol) effects
on the binding free energy. These residues cluster further from the hot spots and outside the
shell of moderately destabilizing residues (Figure 3). The observed pattern of an energetically
important hydrophobic interface core surrounded by a shell of energetically less important
residues is not uncommon to protein–protein interfaces25; 26.
Other mutations were made to UbcH7 and E6AP to serve as controls. In the UbcH7–E6AP
crystal structure, R52 of UbcH7 is solvent exposed and situated opposite the binding interface.
Mutation of this residue to alanine resulted in wild type binding affinity (Table 1). Similarly,
no change in binding free energy was observed upon mutating the E6AP catalytic cysteine to
alanine (C820A) (Table 1). Previous studies on the WWP1 HECT domain found that a double
proline mutation in the hinge connecting the N and C lobes resulted in reduced ligase
activity12. To confirm that the impaired activity arises from restricted conformational
flexibility and not perturbed binding, the analogous positions in E6AP were mutated to prolines
(S739P N741P). The resulting mutant bound UbcH7 with wild type affinity (Table 1).
Charge swap mutations at the UbcH7–E6AP interface
To identify charged amino acids engaged in electrostatic interactions across the interface we
measured binding affinities of 10 UbcH7–E6AP charge swap mutants (Table 1). The binding
affinities from the charge swap experiments were grouped into the same categories as the
alanine mutant affinities. Six of the mutants lost > 1.0 kcal/mol of binding free energy. These
include UbcH7 helix 1 mutants R5E, R6E, and K9E as well as loop 7 charge swaps K96E and
K100E. The helix 1 mutants form inter-chain (R5 and R6) and intra-chain (K9) hydrogen bonds
to backbone oxygen atoms. The D652R mutation was also largely destabilizing, possibly
because of a loss of interaction with K100. Three of the remaining charge swap mutants
displayed less significant losses in binding energy (E60R, K64E, and D641K). The E93R
mutant displayed a large gain in binding energy that may be the result of a new hydrogen bond
with the Q637 E6AP side chain.
Only two side chain–side chain charged interactions are present across the interface, K100–
D652 and K96–D641. We proceeded to test the mutant pairs for an altered specificity
interaction. The effects from K100E–D652R interaction were as unfavorable as the effects of
either single mutant (ΔΔGbind of 1.6 kcal/mol). In contrast, the K96E–D641K mutant pair
displayed a charge swap interaction that was more favorable than the wild type interaction
(ΔΔGbind of −0.8 kcal/mol). For the purpose of creating an altered specificity UbcH7–E6AP
pair, the K96–D641K mutant pair would only achieve specificity towards E3s because the
D641K mutant displays no defects in binding wild type UbcH7. A sub-optimal K96–D641K
salt bridge in the wild type interaction could give rise to such results. These findings suggest
that creating an altered specificity UbcH7–E6AP pair using a charge swap interaction may
prove difficult.
Ubiquitin transfer rates correlate with UbcH7-E6AP binding affinity
Ubiquitin transfer assays were used to assess if changes in UbcH7–E6AP binding affinity
influence the rate ubiquitin is transferred to E6AP. Activity assays were not performed with
mutant UbcH7 proteins because of potential complications from altered E1-UbcH7 activity.
All E6AP mutants were tested in reactions containing radiolabeled ubiquitin, E1, UbcH7, ATP
and an ATP regenerating system. Each reaction was quenched in SDS-PAGE loading buffer
lacking β-ME, separated by SDS-PAGE, and ubiquitin-modified proteins were visualized
using a phosphorimager (Figure 4(a)). Ubiquitin-modified E6AP appears as two bands and
UbcH7 as a single band. The wild type reaction quenched in loading buffer containing β-ME
demonstrates that the ubiquitin modifications to both UbcH7 and the faster migrating E6AP
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band are mediated via thioester linkages (denoted with ∼). The slower migrating E6AP band
that is resistant to treatment with β-ME likely represents ubiquitin modification via an
isopeptide bond (denoted with –). No ubiquitin-modified E6AP is observed in reactions using
the catalytic cysteine mutant (C820A) or the control lacking E6AP.
Phosphoimaging software was used to quantitate the total amount of Ub∼E6AP formed in
each reaction as well as the amount of Ub∼UbcH7 (Figure 4(b)). Ub-UbcH7 levels were not
constant between the various reactions indicating that the rates of Ub∼E6AP formation were
partially limited by the E1/UbcH7 reaction rates. Indeed, in reactions with the tighter binding
E2-E3 pairs the Ub∼UbcH7 band was very weak suggesting that the rate of Ub∼E6AP
formation depended almost entirely on the E1/UbcH7 reaction rate. Previously, we have shown
that E3 and E1 binding to UbcH7 are mutually exclusive and that saturating amounts of E3
can inhibit the E1/E2 transfer step23. We do not believe that is occurring in this case as the E3
concentrations are well below saturating levels. Despite being partially limited by the E1/E2
transfer step, there is still a correlation between the amount of Ub∼E6AP formed and the E2/
E3 binding affinities (correlation coefficient = 0.58). E6AP hot spot mutants Y645A, D652R,
F690A, and M653A as well as Y694L, M654A, and S739P N741P formed less than 55% of
the ubiquitin-E6AP observed in the wild type reactions. All the E6AP mutants displaying
enhanced binding affinity resulted in an increase in the formation of ubiquitin-E6AP. There
are a few outliers. L639A and L635A weaken binding by > 1 kcal / mol, but do not show a
reduced amount of Ub∼E6AP formed. However, there is a greater build up of Ub∼UbcH7 for
these two reactions than for the wild type reaction. Overall, the results indicate that E2/E3
binding affinity does affect E2/E3 ubiqutin transfer rates, but that there could be additional
important factors such as on and off rates, rate of transfer within the bound complex and the
affinity of ubiquitin charged E2 for the E3.
UbcH7–E6AP hot spots are essentially conserved in the UbcH8–E6AP interaction
The hot spot residues in UbcH7, F63, K96 and K100, are conserved in UbcH8 (F62, K95 and
K99). To confirm that these residues are playing the same role at the UbcH8–E6AP interface
we mutated them to alanine and measured affinity for E6AP. The UbcH8 F62A mutation
abolished binding to E6AP. The K95A and K99A mutations proved to be destabilizing with
losses in binding energy of 0.9 and 1.3 kcal/mol respectively (Table 2). In both E2s, the double
loop 7 mutants show nearly additive effects from the single mutants, but still the combined
destabilization is less than the loop 4 phenylalanine mutation. We also tested our panel of E6AP
mutants with UbcH8 in binding assays. There is a striking similarity in the binding affinities
of UbcH7 and UbcH8 for E6AP mutants (Figure 5). Only two significant discrepancies are
observed and these are L639A and D641K; both are stabilizing with UbcH8 yet destabilizing
with UbcH7. These results show that hot spots at the UbcH7–E6AP interface are also hot spots
at the UbcH8–E6AP interface.
Redesigning UbcH5b to bind E6AP
To further explore the determinants of E2-E6AP binding specificity we characterized a set of
mutations that were rationally designed to induce UbcH5b to bind more tightly to E6AP. Our
first design strategy was to mutate residues in UbcH5b that map to hot spot positions in UbcH7.
We made the S94K and T98K single and double mutants in UbcH5b and measured binding to
E6AP (Figure 6). The S94K mutant destabilized binding by 0.5 kcal/mol while the T98K
strengthened binding by 0.4 kcal/mol. The double mutant bound weaker than wild type UbcH5b
but stronger than the S94K single mutant. A possible explanation for this result is that the extra
residue present in UbcH7/8 loop 7 (Figure 2(a)) may lead to different loop 7–E6AP interactions
in UbcH5b. From these results it is clear that conserving the hot spot residues from UbcH7 is
not sufficient to induce low micromolar binding with E6AP.
Eletr and Kuhlman Page 5
J Mol Biol. Author manuscript; available in PMC 2008 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
To further search for UbcH5b mutations that could increase affinity for E6AP we examined
the E2 multiple sequence alignment for residues that were not conserved between UbcH7 and
UbcH5b but were located at the E6AP–UbcH7 interface. The only residue that differs between
the proteins and had an affect on UbcH7–E6AP affinity is serine 4 on UbcH7, which is a leucine
in UbcH5b. Somewhat surprisingly, mutating this leucine on UbcH5b to serine (L3S) resulted
in a significant gain of 1.2 kcal/mol in binding energy (KD of 23 M) (Figure 6). This mutation
was tested in conjunction with the S94K and T98K mutants mentioned above, and the L3S
T98K double mutant bound E6AP with UbcH7/8-like affinity. So although the serine at residue
4 in UbcH7 is not making strong favorable interactions with E6AP, the residue located at this
position can have a significant impact on E2-E6AP binding specificity. The leucine at this
position in UbcH5b is dictating specificity by disfavoring interactions with E6AP.
Discussion
The sequence determinants of E2-E6AP binding affinity and specificity have been studied by
mutational analysis. The major findings can be summarized as follows. (1) a F63 in loop 4 of
an E2 is necessary but not sufficient for tight E2–E6AP binding affinity as the 5 E2s that were
characterized with this phenylalanine bind with affinities ranging from 5–180 M. Of these E2s
only UbcH7 and UbcH8 bind E6AP with low micromolar affinity. (2) In addition to F63, three
side chains on UbcH7 contribute > 1 kcal/mol to the binding free energy between UbcH7 and
E6AP. Two of these (K96 and K100) are located on the periphery of the interface and are not
conserved in other E2 subfamilies that bind more weakly to E6AP. (3) The E6AP side chains
that contribute most to binding UbcH7 are hydrophobic and surround the F63 binding cleft.
(4) Residues that are not hot spots for the UbcH7-E6AP interaction can contribute significantly
to E2-E6AP binding specificity. Mutating L3 of UbcH5b to a serine led to a ∼10 fold increase
in UbcH5b-E6AP affinity.
An important question that remains is whether the interactions that determine E6AP-E2
specificity will translate to other E2-HECT interfaces. Much of the initial work on E2-HECT
specificity focused on E6AP and S. cerevisiae Rsp5. Different techniques yielded conflicting
results as to which E2s these E3s preferred. Studies using the yeast two-hybrid method showed
that E6AP selectively interacts with UbcH7 and UbcH8 while Rsp5 prefers UbcH5a and
UbcH620. Other results using substrate or E3 ubiquitination assays show that UbcH5a and
UbcH7 support equal E6AP activity or that Rsp5 is not active with UbcH618; 19; 22. One
consistent finding was that Rsp5 prefers UbcH5a. Many human HECT E3s are closely related
to yeast Rsp5 in their HECT domain as well as N-terminal substrate binding domains (Nedd4,
Nedd4L, Smurf1/2, WWP1/2 and AIP4 in humans)27. A sequence alignment of the E2 binding
region of HECT E3s (Figure 7) shows that within the Rsp5 subfamily there are conserved
residues not present in E6AP. Some of these differences map to a loop that is 1-3 residues
shorter than E6AP in the Rsp5 subfamily. In more structurally defined positions notable
differences are observed at E6AP residues D641 (W in Rsp5 subfamily), V634 (D/E), and
Y645 (N), and F690 (Y). In an attempt to optimize the UbcH7–Smurf2 interaction, Ogunjimi
et al found two mutations to Smurf2 that were capable of enhancing catalytic activity in
vitro and in vivo13. These mutations, H547I and Y581F, replaced polar groups in the binding
groove with hydrophobic residues observed in E6AP (I655 and F690). Other Rsp5 family
members maintain the hydrophobic nature of I655. Whether subtle differences within other
Rsp5 family members will drive specificity towards the UBC4/5 family or towards other E2
families with a F63 remains undetermined. Our results show that a subtle difference between
UBC4 and UbcH5b indeed affects binding to E6AP.
Our in vitro ubiquitination assays with E6AP mutants demonstrate that E2-E3 affinity
influences the rate ubiquitin∼HECT thioesters can be formed. In vivo there will be the added
complexity that a variety of E3s will be competing for E2 binding sites which could make E3
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conjugation rates more sensitive to E2-E3 affinity. Additionally, the study by Ogunjimi et al.
found that an auxiliary protein Smad7 was able to bind both UbcH7 and the Smurf2 E3 via its
WW domain and effectively enhance the activity of Smurf213. This finding suggests that in
some cases the specificity of E2-E3 interactions may reside in a tertiary protein. Discovering
which E2-E3 pairs functionally interact in the cell is a challenging problem. Introducing E2s
and E3s with redesigned binding specificities into the cell may provide one route for
deciphering the importance of specific interactions. Our study (and others like it) on the
determinants of E2-E3 specificity lay the foundation for such efforts.
Materials and Methods
Protein Purification
UbcH7, ubiquitin, and E6AP expression plasmids have been previously described23. All other
clones were obtained in or subcloned into pGEX vectors with N-terminal GST-tags followed
by a thrombin recognition sequence. Vectors harboring S. cerevisiae UBC4 and human
UbcH5b, UbcH8, UbcH10, Rad6b, and UbcH2 were kindly provided by Marc Timmers.
Human Ubc12 and Ubc9 were kindly provided by Brenda Schulman and Jon Huibgretse
respectively. Point mutations were introduced using the QuickChange® sitedirected
mutagenesis protocol (Stratagene). All vectors were verified by DNA sequencing.
Proteins were expressed overnight at 25 °C with 0.3 mM IPTG in the BL21(DE3) strain of E.
coli. Cells were disrupted by sonication and the resulting lysates were cleared by
ultracentrifugation. UbcH7 was purified by metal chelating sepharose followed by cation
exchange and gel filtration. Ubiquitin was purified by metal chelating sepharose followed by
thrombin cleavage and gel filtration. The HECT domain of E6AP and all other E2s were
purified by glutathione sepharose followed by thrombin cleavage, anion exchange and gel
filtration. For the Y694A E6AP mutant we were not able to purify a sufficient amount of
protein, so instead we tested the Y694L mutation. Proteins were concentrated using Centricon®
and Centriprep® centrifugal concentrators. Extinction coefficients used to determine protein
concentrations were calculated using the method of Gill and von Hipple28.
Isothermal Titration Calorimetry Binding Assay
A Microcal-VP-ITC was used to measure the binding thermodynamics of unmodified UbcH7
for E6AP (Supplementary Figure 1). The experiment was performed at 25° C using 700 M
UbcH7 in the sample syringe and 1.45 mL of 35 M E6AP in the sample cell. Forty-one 5 L
injections of UbcH7 were performed at 5 minute intervals. The heat of dilution of UbcH7 was
calculated as the average of the final three titrations and this value was subtracted from the
dataset. Origin software was used to fit the data to a single-site binding model and determine
the stoichiometry (N) and thermodynamic parameters of binding ΔHbind, ΔGbind and ΔSbind.
Fluorescence Polarization Binding Assays
Binding assays, data analysis, and labeling of the E2 enzymes with bodipy (507/545)-
iodoacetamide (Molecular Probes) has been previously described23. Starting concentrations
for bodipy-E2 depended on the extent of conjugated fluorophore and typically fell in the range
of 0.5-2.0 M. Manual titrations were performed using wild type and mutant E6AP(HECT)
stock solutions that varied based on yield and strength of the interaction. All binding assays
were performed at room temperature in 20 mM KH2PO4 pH 7.0, 150 mM NaCl and 5 mM β-
mercaptoethanol (β-ME). For each binding experiment, nine polarization readings were
collected and averaged at twenty concentrations of E6AP(HECT). Data was fit to a single-site
binding model using nonlinear regression with SigmaPlot software to yield parameters for
Pmin (starting polarization), Pmax (maximum polarization), and KD (dissociation constant).
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In Vitro Ubiquitin Transfer Assay
Isotopic labeling of ubiquitin with 32P was carried out using the PKAce™ kit (Novagen)
according to the manufacturer's protocol. The labeling reaction was quenched with a 10-fold
molar excess of protein kinase A inhibitor (PKI 6-22 Amide, EMD Biosciences). Assays were
carried out at 4 °C for 20 minutes in 50 L volumes containing 20 mM Tris pH 7.5, 50 mM
NaCl, 10 mM MgCl2, 0.2 mM β-ME, 2 mM ATP, 10 mM creatine phosphate, 10 U/ml creatine
kinase, 5 M 32P-ubiquitin, 50 nM human E1 (Boston Biochem), 1 M UbcH7, and 1 M wild
type or mutant E6AP(HECT). Reactions were initiated with the addition of 32P-ubiquitin and
terminated with 2X SDS-PAGE loading buffer with or without 200 mM β-ME . SDS-PAGE
was used to separate 30 L of the final reactions and gels were then dried and exposed to a
phosphor screen. A phosphorimager and ImageQuant 5.0 software (GE Healthcare) were used
to detect and quantify 32P-ubiquitin bands. The experiment was performed in duplicate
(Supplementary Figure 2).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Cartoon representation of the UbcH7–E6AP crystal structure11. (a) The E6AP N-terminal lobe
(blue) and C-terminal lobe (cyan) are connected by a 3 residue hinge (red). E6AP uses a ∼80
amino acid subdomain in the N-terminal lobe to bind UbcH7 (green). Catalytic cysteine side
chains of UbcH7 and E6AP are shown as van der Waals radii. (b) Close up of the UbcH7–
E6AP interface. The most significant contacts arise from UbcH7 helix 1 (H1) as well as loops
4 and 7 (L4 and L7) which interact with E6AP helices 7 and 8 (H7 and H8) and the H7-S5
loop. Figure was generated using PDB 1C4Z11 and PYMOL (http://www.pymol.org).
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Figure 2.
E6AP selectively interacts with UbcH7 and UbcH8. (a) Sequence alignment of the E3 binding
regions of a subset of E2 enzymes. The dots indicate UbcH7 residues used to bind E6AP and
are colored by the change in UbcH7–E6AP binding energy associated with mutating the side
chain to alanine (or glycine) according to Figure 3. (b) Fluorescence polarization binding assays
of E6AP(HECT) with each of the E2s listed in (a). The results show that only UbcH7 and
UbcH8 interact with low micromolar affinity and that UBC4 and UbcH5b of the closely related
UBC4/5 subfamily bind E6AP significantly weaker. Aside from UbcH7 and UbcH8, all E2s
have sub-optimal amino acids at hot spots for E6AP.
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Figure 3.
Mapping ΔΔGbind from alanine scan studies onto the UbcH7–E6AP structure. The interface
view was obtained by rotating UbcH7 180° about the y-axis. Individual amino acids are colored
by the change in binding free energy observed upon making the indicated mutation. F63 of
UbcH7 is the most important residue for binding. Other hot spots include E6AP residues lining
the hydrophobic groove that contacts F63 as well as K96 and K100 of UbcH7. Residues with
smaller contributions to binding form a shell around F63 and the hydrophobic E6AP groove.
Figure was generated using PDB 1C4Z11 and PYMOL.
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Figure 4.
In vitro activity of E6AP mutant proteins. (a) A ubiquitin transfer assay was used to detect the
formation of ubiquitin-E6AP thioester in reactions containing 5 M 32P-ubiquitin, 50 nM E1,
1 M wild type UbcH7 and 1 M wild type or mutant E6AP and an ATP regenerating buffer.
The ubiquitin-E6AP thioester (Ub∼E6AP) is reduced in the control reaction quenched in β-
ME while the isopeptide-linked ubiquitin (Ub–E6AP) is retained. (b) For each reaction the
total ubiquitin-E6AP formed was quantified and normalized to the wild type reaction. The
assay was repeated (Supplementary Figure 1) and the averaged counts for each mutant is plotted
versus the experimentally determined ΔΔG°bind. Error bars represent standard deviation of
relative ub-E6AP formed and the standard error of ΔΔG°bind.
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Figure 5.
UbcH7 and UbcH8 form nearly identical interactions with E6AP. Bar graph comparing the
observed change in binding free energy of E6AP mutants for UbcH7 and UbcH8(C97S). Nearly
all E6AP interface residues contribute similar energy to binding UbcH7 and UbcH8(C97S).
The two significant differences (L639A and the charge swap D641K) may arise from a slight
difference in loop L7 of UbcH7 and UbcH8. The F690A mutant was not tested with UbcH8.
Eletr and Kuhlman Page 14
J Mol Biol. Author manuscript; available in PMC 2008 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 6.
Rationally manipulating UbcH5b to enhance binding to E6AP. Three UbcH5b positions were
mutated and tested for their contribution to binding E6AP. UbcH5b mutants containing the
UbcH7 hot spot lysine(s) (S94K and T98K) alone were not able to significantly enhance
binding. The L3 UbcH5b residue is a serine in UBC4, UbcH7 and UbcH8, and the L3S mutation
resulted in a large increase in binding affinity for E6AP. The L3S T98K double mutant was
capable of binding E6AP with UbcH7/8-like affinity. Interestingly the S94K mutation is
destabilizing except when present with the L3S mutation.
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Figure 7.
Multiple sequence alignment of the E2-binding subdomain of Rsp5 family members and E6AP.
The dots are colored by the change in UbcH7–E6AP binding energy associated with mutating
the E6AP side chain to alanine according to Figure 3. Amino acids lining the hydrophobic
groove that interacts with F63 of E2s is generally hydrophobic and/or aromatic in the Rsp5
family of E3s. The Rsp5 family members have a 1-3 residue deletion in the H7-S5 loop and
numerous non-conservative substitutions at E6AP residues. Both of these differences likely
play a role in dictating E2-HECT specificity.
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Table 2
Measured ΔΔ°Gbind (kcal/mol) of UbcH7–E6AP hot spots in UbcH8(C97S)
UbcH7 UbcH8(C97S)
F63A 3.0 F62A DNB
K96A 1.1 K95A 0.9
K100A 1.3 K99A 1.3
K96A K100A 2.1 K95A K99A 2.1
DNB, does not bind in our assay.
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